parecoxib/valdecoxib
ApprovedTerminated 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Pain, Post Surgical
Conditions
Pain, Post Surgical
Trial Timeline
Jun 1, 2004 → Jul 1, 2004
NCT ID
NCT00660855About parecoxib/valdecoxib
parecoxib/valdecoxib is a approved stage product being developed by Pfizer for Pain, Post Surgical. The current trial status is terminated. This product is registered under clinical trial identifier NCT00660855. Target conditions include Pain, Post Surgical.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00660855 | Approved | Terminated |
Competing Products
20 competing products in Pain, Post Surgical